Emerging medical therapies for congenital adrenal hyperplasia
- PMID: 30984389
- PMCID: PMC6446492
- DOI: 10.12688/f1000research.17778.1
Emerging medical therapies for congenital adrenal hyperplasia
Abstract
Congenital adrenal hyperplasia has traditionally been treated with daily oral doses of glucocorticoids and mineralocorticoid supplements. Such therapy does not precisely replicate the adrenal cortex's circadian pattern. As a consequence, patients are intermittently overtreated or undertreated leading to growth suppression in children, excess weight gain and altered metabolism. Several new treatments are on the horizon. This article will summarize some new potential therapies as adjuncts to, or replacement for, standard therapy.
Keywords: congenital adrenal hyperplasia; treatment.
Conflict of interest statement
Competing interests: The author has served as a medical consultant to Neurocrine Biosciences, San Diego, CA and has been considered for participation in several planned clinical trials.
References
-
- National Newborn Screening and Global Resource Center: National Newborn Screening System. In: Center NNSGR, ed. Newborn Screening Reports and Publications. National Newborn Screening & Global Resource Center;2006;2017.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
